Hansa Biopharma AB (publ) (STO:HNSA)
Sweden · Delayed Price · Currency is SEK 34.36
+1.46 (4.44%)
At close: Dec 30, 2025
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 3.5 billion as of December 31, 2025. Its market cap has increased by 69.72% in one year.
Market Cap
3.50B
Enterprise Value
4.17B
Revenue
178.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.36
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 3.50B, an increase of 11,284.96%. That is a compound annual growth rate of 30.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 3.50B | 31.53% |
| Dec 30, 2024 | 2.66B | 93.47% |
| Dec 29, 2023 | 1.37B | -46.77% |
| Dec 30, 2022 | 2.58B | -34.64% |
| Dec 30, 2021 | 3.95B | -63.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.91B |
| Getinge AB | 59.27B |
| Sectra AB | 48.17B |
| Camurus AB | 37.07B |
| Medicover AB | 33.29B |
| Asker Healthcare Group AB | 32.59B |
| BioArctic AB | 27.78B |
| Elekta AB | 21.80B |